Abstract

Background: This study aims to follow a cohort of COPD patients so as to measure the frequency of acute exacerbation and annually correlate it with the BODE index and with the cellularity of induced sputum (IS) at admission. Methods: The longitudinal study followed 44 COPD patients for 30 months. COPD severity was determined according to the GOLD criteria and the cellularity of induced sputum was quantified. For two years, COPD patients were assessed for acute exacerbation, characterized by an intensification of COPD symptoms that required additional antibiotics or/and systemic corticosteroids. All patients were smokers and returned for regular clinical visits. IS was collected from all patients when admitted to the study and cellularity was quantified. BODE index was measured in the 1st and 2nd years. Results: Data showed that the GOLD criteria did not correlate with acute exacerbation, but the BODE index did (r = 0.587). Neutrophils and macrophages from induced sputum had good correlation with FEV₁ and there is a phenotypic profile for which acute exacerbation is more recurrent, which is chronic bronchitis (p<0.038). Conclusions: The frequency of acute exacerbation is similar to that of world medical literature, approximately 2 episodes per annum. The results suggest that BODE index could be used to identification of subgroup of COPD patients which has more acute exacerbation.

Keywords:

BODE index, COPD, induced sputum,

References

Competing interests

The authors have no competing interests.

Open Access Policy

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Copyright

The authors have no competing interests.